Condition: Severe Hemophilia A · Sponsor: Hangzhou Gensciences Biopharmaceutical Co., Ltd.
The indication for this product is to control and prophylaxis in patients with Hemophilia A (congenital Factor VIII deficiency): The Primary Objective： To evaluate the efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection (FRSW107) for prophylactic treatment in previously treated patients with severe Hemophilia A. Secondary Objectives： To evaluate the health-related quality of life, pharmacokinetic (PK) profiles, safety and immunogenicity of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection (FRSW107) for prophylactic treatment in previously treated subjects with severe Hemophilia A.
This description comes directly from the study's public registry record.
Lijia Liu · + 86 18645377793 · lijialiu@gensciences.cn
Renchi Yang, PhD
Always discuss trial participation with your own doctor first.
| Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College | Tianjin, Tianjin Municipality, China | Recruiting |
| Fuyang Hospital, Affiliated to Anhui Medical University | Fuyang, China | Not Yet Recruiting |
| Fujian Medical University Union Hospital | Fuzhou, China | Not Yet Recruiting |
| Nanfang Hospital of Southern Medical University | Guangzhou, China | Not Yet Recruiting |
| Anhui Provincial Hospital | Hefei, China | Not Yet Recruiting |
| Jinan central hospital | Jinan, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Kunming Medical University | Kunming, China | Not Yet Recruiting |
| The First Affiliated Hospital of Guangxi Medical University | Nanning, China | Not Yet Recruiting |
| Affiliated Hospital of Nantong University | Nantong, China | Not Yet Recruiting |
| The First Affiliated Hospital of Nanyang Medical College | Nanyang, China | Not Yet Recruiting |
| Qinghai Provincial People's Hospital | Qinghai, China | Not Yet Recruiting |
| The Second Hospital of Shanxi Medical University | Taiyuan, China | Not Yet Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07684898